Madrigal Pharmaceuticals Inc (MDGL)
329.17
+12.08
(+3.81%)
USD |
NASDAQ |
Nov 21, 16:00
329.00
-0.17
(-0.05%)
After-Hours: 20:00
Madrigal Pharmaceuticals Market Cap: 7.179B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 6.916B |
| November 19, 2024 | 6.852B |
| November 18, 2024 | 6.619B |
| November 15, 2024 | 6.294B |
| November 14, 2024 | 6.601B |
| November 13, 2024 | 6.874B |
| November 12, 2024 | 7.395B |
| November 11, 2024 | 7.408B |
| November 08, 2024 | 7.649B |
| November 07, 2024 | 7.739B |
| November 06, 2024 | 7.377B |
| November 05, 2024 | 7.363B |
| November 04, 2024 | 7.226B |
| November 01, 2024 | 6.970B |
| October 31, 2024 | 5.656B |
| October 30, 2024 | 4.710B |
| October 29, 2024 | 4.750B |
| October 28, 2024 | 4.733B |
| October 25, 2024 | 4.594B |
| October 24, 2024 | 4.426B |
| October 23, 2024 | 4.415B |
| October 22, 2024 | 4.440B |
| October 21, 2024 | 4.555B |
| October 18, 2024 | 4.676B |
| October 17, 2024 | 4.590B |
| Date | Value |
|---|---|
| October 16, 2024 | 4.701B |
| October 15, 2024 | 4.714B |
| October 14, 2024 | 4.698B |
| October 11, 2024 | 4.670B |
| October 10, 2024 | 4.592B |
| October 09, 2024 | 4.599B |
| October 08, 2024 | 4.727B |
| October 07, 2024 | 4.685B |
| October 04, 2024 | 4.545B |
| October 03, 2024 | 4.505B |
| October 02, 2024 | 4.561B |
| October 01, 2024 | 4.565B |
| September 30, 2024 | 4.628B |
| September 27, 2024 | 4.612B |
| September 26, 2024 | 4.644B |
| September 25, 2024 | 4.695B |
| September 24, 2024 | 4.843B |
| September 23, 2024 | 4.901B |
| September 20, 2024 | 5.070B |
| September 19, 2024 | 5.260B |
| September 18, 2024 | 5.063B |
| September 17, 2024 | 5.067B |
| September 16, 2024 | 5.068B |
| September 13, 2024 | 5.250B |
| September 12, 2024 | 5.097B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
927.76M
Minimum
Apr 03 2020
7.739B
Maximum
Nov 07 2024
2.731B
Average
1.822B
Median
Market Cap Benchmarks
| Corcept Therapeutics Inc | 5.863B |
| ADMA Biologics Inc | 5.034B |
| 89bio Inc | 985.34M |
| Sarepta Therapeutics Inc | 10.56B |
| Matinas BioPharma Holdings Inc | 2.950M |
Market Cap Related Metrics
| PEG Ratio | -0.4287 |
| Price to Book Value | 9.238 |
| Price | 329.17 |
| Earnings Yield | -7.63% |
| PEGY Ratio | -0.4287 |